Viewing Study NCT03684694


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2026-03-02 @ 6:43 PM
Study NCT ID: NCT03684694
Status: TERMINATED
Last Update Posted: 2024-02-06
First Post: 2018-09-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy Study of Loncastuximab Tesirine + Ibrutinib in Diffuse Large B-Cell or Mantle Cell Lymphoma
Sponsor: ADC Therapeutics S.A.
Organization: